{"entity":{"id":"nct00002622","kind":"trial","name":"Talc in Treating Patients With Malignant Pleural Effusion","aka":[],"tldr":"A phase 3 trial of Talc in Metastatic cancer, run by Alliance for Clinical Trials in Oncology, completed.","summary":"Talc in Treating Patients With Malignant Pleural Effusion is a phase 3 interventional study registered as NCT00002622 by Alliance for Clinical Trials in Oncology, with 501 participants recorded, started 1994-12 and reaching its primary completion in 2005-03. Interventions recorded: talc, Talc. Conditions recorded: Metastatic Cancer.\n\nLinked to the drug Talc because the registry names it among its interventions and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00002622","url":"https://clinicaltrials.gov/study/NCT00002622"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["talc-sclerosant"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00002622","phase":"3","setting":"Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study","sponsor":"Alliance for Clinical Trials in Oncology","enrolled":501,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00002622/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"talc-sclerosant","kind":"drug","name":"Talc (intrapleural)","route":"/drugs/talc-sclerosant/"}]}}